GLP-1 Weight Loss in Reno (2026)

Reno at a Glance

About GLP-1 Access in Reno

Reno is one of the largest cities in Nevada, located in Nevada with a population of approximately 264,000. Telehealth is legal in Nevada, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to Reno ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The Reno metro area brings the wider telehealth-serviceable population to roughly 490,596 residents, extending beyond the city's 264,165 city-proper population.

Nevada's adult obesity rate is approximately 34.2% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. Nevada ranks #31 of 50 states for adult obesity prevalence — near the national middle — and telehealth gives Reno residents a fast, private alternative to scheduling with a local obesity-medicine specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

Nevada Medicaid does not currently cover GLP-1s for weight loss alone (Diabetes only), which is why cash-pay compounded semaglutide or tirzepatide — averaging $199/month — is the realistic path for most Reno residents seeking obesity treatment outside a type 2 diabetes diagnosis.

Looking beyond Reno? See all GLP-1 providers in Nevada, or read our Nevada Medicaid GLP-1 coverage & prior-authorization guide.

Browse by Medication

Browse all 338 providers with undisclosed coverage on the Nevada page →

In-Person vs Telehealth in Reno

Patients in Reno have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to Nevada addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in Nevada varies by plan^[4].

In-person weight-management clinics in Reno (47 in our directory)

From the NPI registry, cross-checked against obesity-medicine and bariatric taxonomy codes — mostly endocrinology, diabetes & metabolism.

• Amanjot Lehil — Endocrinology, Diabetes & Metabolism, 780 Kuenzli St
• Ann Owen — Endocrinology, Diabetes & Metabolism, 781 Mill St
• Ann Owen, M.D. Ltd. — Endocrinology, Diabetes & Metabolism, 781 Mill St
• Carol Cheney — Endocrinology, Diabetes & Metabolism, 1500 East Second St.
• Claude Lardinois — Endocrinology, Diabetes & Metabolism, 1700 Aquila Ave
• Community Care Services LLC — Endocrinology, Diabetes & Metabolism, 10085 Double R Blvd Ste 310
• Daniel Caruso — Endocrinology, Diabetes & Metabolism, 5605 Riggins CT
• Daniel R Caruso MD PC — Endocrinology, Diabetes & Metabolism, 5065 E. Riggins Court

Browse all 47 Reno clinics in the directory →

Cost of GLP-1 Medications in Reno

Brand-name Wegovy in Reno typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $199/month in Nevada, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Other Cities in Nevada

Comparing options beyond Reno? GLP-1 telehealth providers ship statewide, so these Nevada cities have their own dedicated pricing and provider breakdowns:

Frequently Asked Questions